Balsalazide

Amber-G

Brand Name(s):Colazide

Indication:Ulcerative colitis (mild-moderate, active) and for maintenance of remission

Rationale:

Considered:May-07

Review Date:May-24

Comments:
NICE NG130
Ulcerative colitis: management
May 2019
…………………………
NICE CG 166
See document at:http://www.nice.org.uk/nicemedia/live/14189/64216/64216.pdf
Issued June 2013
…………………………
Monitoring for FBC & renal function is required:
a) Prior to starting Balsalazide then
b) 4-6 weeks after starting Balsalazide then
c) annually
Reference:
Local Gastroenterology advice is based upon British Society of Gastroenterologists Guideline for Management of Inflammatory Bowel Disease (2010).
SPC Colazide (Balsalazide).
March 2012